Drexel University College of Medicine is the medical school of Drexel University. The medical school represents the consolidation of two medical schools: the first U.S. medical school for women and the nation's first college of homeopathy.

During the past decade, Drexel University College of Medicine conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 62 clinical trials were completed, i.e. on average, 193.8% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 34 clinical trials were completed. i.e. 3400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Drexel University College of Medicine" #1 sponsor was "National Cancer Institute (NCI)" with 7 trials, followed by "Celgene" with 5 trials sponsored, "Boston Scientific Corporation" with 4 trials sponsored, "Gilead Sciences" with 4 trials sponsored and "Knopp Biosciences" with 4 trials sponsored. Other sponsors include 108 different institutions and companies that sponsored additional 80 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Drexel University College of Medicine" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 8 trials as a collaborator, "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Pfizer" with 4 trials as a collaborator, "Cystic Fibrosis Foundation" with 3 trials as a collaborator and "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator. Other collaborators include 105 different institutions and companies that were collaborators in the rest 109 trials.

According to Clinical.Site data, the most researched conditions in "Drexel University College of Medicine" are "Heart Failure" (11 trials), "HIV Infections" (9 trials), "Cystic Fibrosis" (8 trials), "Alzheimer's Disease" (6 trials) and "Amyotrophic Lateral Sclerosis" (6 trials). Many other conditions were trialed in "Drexel University College of Medicine" in a lesser frequency.

Most popular intervention types in "Drexel University College of Medicine" are "Drug" (95 trials), "Other" (24 trials), "Device" (19 trials), "Biological" (15 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (32 trials), "Laboratory Biomarker Analysis" (7 trials), "Quality-of-Life Assessment" (5 trials), "Cisplatin" (3 trials) and "Doxorubicin Hydrochloride" (3 trials). Other intervention names were less common.

The vast majority of trials in "Drexel University College of Medicine" are 117 trials for "All" genders and 20 trials for "Female" genders.

Currently, there are NaN active trials in "Drexel University College of Medicine". undefined are not yet recruiting, undefined are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 95 completed trials in Drexel University College of Medicine, undefined suspended trials, and 22 terminated clinical trials to date.

Out of the total trials that were conducted in Drexel University College of Medicine, 3 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 66 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 11 trials that are defined as “Not Applicable".